Biochemical analysis of activation-induced cytidine deaminase (AID) from bony fish: insights into the mechanisms of AID by Dancyger, Alex




Biochemical analysis of Activation-induced cytidine deaminase
(AID) from bony fish: insights into the mechanisms of AID
by
Alex Dancyger (B. Sc Honours)
© Alex Dancyger
A thesis submitted to the School of Graduate Studies in partial fulfillment of the
requirements for the degree of Masters of Science from the department of BioMedical
Sciences of Memorial University of Newfoundland
May 2012
Immunology and Infectious Diseases Research Program
Division of BioMedical Sciences
Memorial University of Newfoundland
St. John's, NL AlB 3V6
Abstract
The properties of Activation-induced cytidine deaminase (AID) necessary for its
role in immunity and lymphoma generation are currently unknown. AID mutants and
species-variants, as compared to wild-type human AID, were identified so as to map out
responsible residues/domains. Variant AIDs were analyzed by alkaline cleavage and
EMSA. AID from bony fish species (lctalurus punctatus and Danio rerio) were
identified as the most divergent from human AID. Dr-AID acted enzymatically similar to
H-AID, while lp-AID was less mutagenic. Point mutations within Ip AID were
generated, substituting the human counterpart amino acid. One mutant rescued lp-AID
enzyme activity to levels seen in H-AID and Dr-AID. The reverse mutation in H-AID
almost fully abolished the deaminating ability of H-AID. DNA-binding kinetics were
tested at different temperatures to analyze if the disparity in activity levels was due to
binding of DNA. The single mutation in lP-AID increases the affinity of AID to bind
ssDNA and this effect is substantially more pronounced at lower temperatures. These
results have provided novel information on AID domains/residues necessary for its
function.
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1. Introduction
1.1 The immune system
The immune system is the body's natural defence, tasked with the recognition and
clearance of pathogens, such as fungi, bacteria and viruses, within a host. It responds to a
myriad of pathogens by being adaptive and self-tolerant. The innate immune system is a
host's first line of defence. This system is comprised of non-specific mechanisms that
provide immediate rather than long lasting protection. The adaptive immune response is
the second line of defence and is composed of two types of leukocytes: T lymphocytes,
whose function is to destroy infected cells and eradicate intracellular pathogens, and B
Iymphocytes, cells that secrete antibodies and attack extracellular pathogens. Bone
marrow represents the dominant site for haemopoiesis where the majority of cells mature.
However, T lymphocytes mature in the thymus, undergoing a series of positive and
negative selections with only the former progressing to maturity and the latter being
marked for termination by apoptosis (Fleisher & Tomar, 1997; Warrington et aI., 2011;
Lanasa and Weinberg, 2011).
There are three types oflymphocytes: T, B and K cells. However, only T and 8
lymphocytes exhibit antigen-specific receptors and memory. T cells can be broadly
divided into T helper (TH) and cytotoxic (Tc) T cells. B cells are Iymphocytes that
produce antibodies and are responsible for humeral mediated immunity. Once 8 cells are
activated by a foreign antigen, proliferation and maturation begins producing plasma cells
that secrete antibodies. Not all 8 cells develop into plasma cells. Some remain as memory
B cells conferring protection upon re-exposure to the same pathogen. Similarly, T cells
undergo clonal selection generating memory T cells. T and B cells are constantly
circulating around the body, migrating to and from blood and tissues (Fleisher & Tomar,
1997; Warrington et aI., 2011; Lanasa & Weinberg, 2011).
Antibodies have two major roles in the immune system: frrst, to bind antigen and
second, to interact with host tissues and effector systems to eradicate foreign pathogens.
The human immune system possesses five isotypes of antibodies: IgM, IgG (which
contains 4 subclasses: IgG 1-4), IgA, IgE and IgD. The basic structure of an antibody
contains four polypeptide chains, two light chains and two heavy chains, which roughly
form a "Y" shaped molecule (Figure 1). One end of the immunoglobulin, known as the
Fab portion, contains the variable (V) regions of each of the light and heavy chains. This
portion gives the antibody its specificity and is the region that binds the antigen. The Fc
portion contains the constant (C) region of the heavy chains, is far less variable and
determines the isotype and effector function of the antibody (Fleisher & Tomar, 1997).
1.2 Primary antibody diversification
An essential step in the development of the vertebrate immune system is V(D)J
recombination. This process of D A rearrangement occurs early in T and B cell
development generating functional immunoglobulins (Ig) and T cell receptors (TCR).
This mechanism of genetic recombination is the only identified site-specific
recombination in higher eukaryotes. Vertebrate Ig and TCR genes are arranged in a linear
fashion and require recombination to be joined into a functional gene. Mammals
possess seven antigen receptor loci: Ig H, K and Aloci, and TCR a, ~,y, and <') loci. Each
locus contains a set of V and J segments, with Ig H and TCR~ and <') possessing additional
D segments flanked by V and J segments. During lymphoid cell maturity, various V-J
and V-D-J segments become linked to form variable and constant region exons that are
spliced together (Figure 2). Failure of a cell to create a successful product that does not
self-react results in apoptosis. However, with multiple types of each segment, there are
many combinatorial possibilities. This phenomenon is responsible for generation the
primary (pre-immune response) diversity ofIg and TCRs (Gellert, 2002).
1.3 Secondary antibody diversification: the role of Activation-induced
cytidine deaminase (AIm
As mentioned previously, the vertebrate immune system has evolved to respond to
a diverse array of pathogens by generating a seemingly infinite number of antigen
receptors. The primary diversity of B cell antigen receptors is first generated through
V(D)J recombination which is the process of rearrangement of gene segments encoding
receptors. The outcome is a naIve (pre-immune) repertoire of antibodies covering broad
specificities but of generally low affinity for a specific antigen. Upon exposure to an
immune challenge, B lymphocytes are activated, migrate to germinal centres within
lymph nodes and begin the process of proliferating and refining their antibody repertoire
through secondary antibody diversification processes (Muramatsu et aI., 2000; Revy et
aI., 2000; Martin et aI., 2002; Okazaki et aI., 2002). The molecular processes responsible
for fine tuning the antibody response are mediated by somatic hypermutation (SHM) and
class switch recombination (CSR) (Figure 3) (Martin et aI., 2002; Muramatsu et aI., 2000;
Okazaki et aI., 2002; Revy et aI., 2000). SHM is the means whereby random point
mutations are introduced in the variable (V) antigen-recognition exons of
immunoglobulin (Ig) genes. Some mutations may result in an enhanced affinity to a
specific pathogen. B lymphocytes harbouring these mutations will be at an advantage for
interaction with a limited amount of antigens resulting in cellular selection for survival
and proliferation. This yields a pool of antibodies with higher affinities for antigens. In
addition to affinity maturation, antibodies also switch isotypes during an immune
response. During this process, the constant region of the antibody heavy chain is changed
from the initial IgM to IgG, IgA or IgE, but the same variable region is retained.
Therefore, class switching does not affect antigen specificity; instead it generates the
ability for the antibody molecule to interact with different effector molecules and carry
out a variety of effector functions necessary for the efficient clearance of pathogens (de
Yebenes & Ramiro, 2006). At the molecular level isotype switching is mediated by class-
switch recombination (CSR). The process of CSR is initiated by double stranded breaks
(DSBs) which are created in the switch (S) regions upstream of the constant (C) exons in
the Ig heavy chain. C~ is exchanged for a downstream C region and the intervening
DNA is excised producing antibodies with new isotypes. While SHM and CSR are
mediated by distinct DNA lesions and recruit different DNA repair machineries, both
processes are initiated by the enzyme Activation-induced cytidine deaminase (AID)
(Martin et aI., 2002; Muramatsu et aI., 2000; Okazaki et aI., 2002; Revy et aI., 2000;
Barreto et aI., 2005; Chaudhuri & Frederick, 2004; Longerich et aI., 2006; Neuberger et
aI., 2005).
Human patients with genetic defects in AID as well as AID deficient mouse
models suffer from Hyper-IgM syndrome, an immunodeficiency characterized by the
inability to clear specific pathogens and carry out CSR leading to an absence of
antibodies other than IgM. The result is recurrent bacterial infections, lymphoid
hyperplasia, autoimmune hepatitis, haemolytic anaemia, thrombocytopenia and an
imbalance in a myriad of immune functions. Therefore AID is essential for secondary
antibody diversification (Dooley et aI., 2006; Durandy, Peran, & Fischer, 2006; Revy et
al.,2000).
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Figure 1. A simplified schematic representation of the structure of an IgG antibody
molecule.
Figure 1. A simplified schematic representation of the structure of an IgG antibody
molecule.
The antibody molecule is composed of three globular regions that form aY-shaped
molecule. The two antigen-binding sites are at the tip of each arm. The antibody molecule
is composed of two heavy (H) chain and two light (L) chains. The separate domains
comprising each chain have been identified The Fab fragment contains the variable (V)
regions of the light and heavy chains and binds antigen The Fc fragment contains the
constant (C) regions of the immunoglobulin molecule.
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Figure 2. V(D)J recombination during B Iymphocyte development.
Figure 2. V(D)J recombination during B lymphocyte development.
V(D)J recombination is the genetic recombination process that occurs in the early
development of immunoglobulins and T cell receptors. During B lymphocyte
development V, D and J segments in the heavy chain and V and J segments in the light
chain are rearranged by the lyphocyte specific enzymes recombination activating genes -1
and -2 (RAG1 and RAG2). RAG 1 and RAG2 splice the variable and constant regions
together. Many different combination are possible generating a diverse primary antibody
repertoire.
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Figure 3. Secondary antibody repertoire generation by somatic hypermutation
(SHM) and class switch recombination (CSR).
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Figure 3. Secondary antibody repertoire generation by somatic hypermutation
(SHM) and class switch recombination (CSR).
SHM and CSR are the two molecular mechanisms responsible for generating the
secondary diversification of antibodies. These processes occur in the germinal centres of
lymph nodes once a B lymphocyte has been activated by exposure to an immune
challenge. SHM introduces point mutations into the antigen-binding region of the
antibody by nucleotide substitutions (arrows). As a result, rearrangement of the variable
Ig genes occurs and antibodies with an increased affinity are generated. CSR is a region-
specific recombination reaction taking place between the switch regions (green ovals).
The ell constant region is exchanged with a downstream constant region (blue boxes).
The resulting antibody has a new effector function.
1.4 The role of AID in cancer
While the action of AID, inserting mutations into nucleic acids, is for the most
part targeted to the immunoglobulin loci, this honing is not flawless. As a result AID acts
promiscuously, mutating and creating DSBs throughout the B cell genome. Prior to the
discovery of AID, it was proposed that a link existed between genes mutated following
secondary antibody diversification and certain B-cell lymphomas with a major hallmark
of disease being the chromosomal translocations between Ig genes and a proto-oncogene
(Gordon et aI., 2003; Mlischen et aI., 2000; Pasqualucci et aI., 1998; Pasqualucci et aI.,
2001; Shen et aI., 1998). Many of the most aggressive B-celllymphomas are initiated in
germinal-centre B cells and contain translocations in V or S regions of Ig genes (Klippers
& Dalla-Favera, 2001; Willis & Dyer, 2000). Specific examples include the BCL-I-IgH
translocation found in mantle-zone lymphoma, the BCL-2-Ig H translocation in follicular
lymphomas and the C-MYC-IgH translocation in Burkitt's lymphoma. Proto-oncogenes
PlMl, MYC, RHOH and PAX5 are also subject to translocation in diffuse large B-cell
lymphoma (DLBCL) (Pasqualucci et aI., 2001). Translocation results in the control of
proto-oncogene expression under the robust IgH enhancer and/or promoters and thus
over-expression and/or constitutive expression (Klippers & & Dalla-Favera, 2001;
Klippers, 2005). Several lines of evidence from both murine and human models have
identified AID as being responsible for the development of lymphomas. First, many of
these proto-oncogene translocations occur at or near WRC hotspot motifs, a ssDNA
trinucleotide motif specifically targeted by AID with a preference for C (W=A/T,
R=AlG), implicating AID involvement (Pasqualucci et aI., 2001). Second, transgenic
mice over-expres ing AID were found to develop tumours (Okazaki et aI., 2003). Third,
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AID is often found expressed in cancer tissues and cell lines where it is not normally
expressed (Bachl et aI., 2001). Fourth, studies on transgenic IL-6 mjce, a model for
Burkitt's lymphoma, showed that AID is required for the c-MYC/IgH translocations when
AID-I- IL-6 transgenic mice lacked these specific translocations (Ramiro et aI., 2004).
Fifth, mice constitutively expressing the proto-oncogene B-cell lymphoma 6 (BCL-6)
demonstrated clonal splenic lymphomas, however when AID expression in these mice
was downregulated lymphoma production decreased (Pasqualucci et aI., 2008). Finally
strong correlations have been observed between the severity of human chronic
lymphocytic leukemia, DLBCL and AID expression (McCarthy et aI., 2003; Reiniger et
aI., 2006). This growing body of evidence strongly supports the implications of AID
activity in the transformation of activated B cells into leukemia and lymphomas as well as
in disease aggressiveness.
1.5 The mechanisms behind the mutagenic activities of AID
Upon its discovery in 1999 AID was initially thought to act as an RNA editing
enzyme which through the modification of mRNA would result in the expression of a
mutagenic protein that could in turn carry out SHM and CSR (Muramatsu et aI., 1999;
Muramatsu et aI., 2000). This idea was largely based on AID's homology to the family
member apolipoprotein B mRNA editing enzyme, catalytic polypeptide I (APOBECI),
an mRNA editing enzyme. Upon further examination it was identified that AID is the
only factor required for secondary antibody diversification processes (Conticello et aI.,
2005; Conticello et aI., 2007). Support for this notion was provided when AID was
heterogeneously expressed in fibroblasts and shown to be the only requirement necessary
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to support SHM and CSR on transcribed substrates (Okazaki et aI., 2002; Yoshikawa et
aI., 2002). Furthermore, interactions between AID and B cell S region DNA going
through CSR was observed (Nambu et aI., 2003). Thirdly, in vitro studies have shown
that AID acts directly on ssDNA and not RNA, dsRNA or dsDNA (Bransteitter et aI.,
2003). These findings fit well with the previous observations that genes that are more
highly transcribed are mutated more frequently by AID presumably because the process
of transcription unwinds D A making it more accessible (Yang & Schatz, 2007).
Experiments show that AID specifically targets ssDNA with a preference for C within
WRC hotspot motifs (W=AlT, R=AlG) (Beale et aI., 2004; Pham et aI., 2003). This
preferential targeting of trinucleotide motifs parallels the pattern of mutations observed in
the 19 loci (Larijani et aI., 2005; Yang & Schatz, 2007). It is extremely unlikely that AID
would act on an mRNA that currently remains unidentified, resulting in the expression of
an AID mutator with the same WRC specificity as AID itself Thus, AID directly
mutates ssDNA at the 19 locus. The current paradigm most widely accepted is that AID
deaminates C to U on ssDNA sequences of 19 genes. Since AID mediates only one type
of mutation, C to U, other mutagenic processes are required to explain the pattern of
SHM mutations observed at the 19 loci (Figure 4). These mutations could be from any
one nucleotide (A, T, C, G) to any of the other four possible nucleotides. The initial AID
mutagenesis creates a U:G mismatch in DNA. Previous work in the field of DNA repair
has shown that this mismatch can be processed by a multitude of different DNA repair
pathways. The U:G mismatch may be a substrate for either the base-excision repair
(BER) or the mismatch repair (MMR) pathways of DNA damage repair. As a results, said
U:G mismatch generated by AID has three possible fates. The first is that the U remains
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unrepaired and is replicated across during cell division, resulting in a T:A transition
mutation during replication. Alternatively the U:G mismatch could be subjected to one or
both of two aforementioned 0 A repair processes. The first is the removal ofthe U base
by uracil-D A glycosylase (UNG) generating an abasic site which could be prone to
strand breakage by apurinic/apyridinic endonuclease (APE I) or a base substitution during
replication resulting in the excision of several nucleotides surrounding the lesion. This
overall process is known as BER. Alternatively, the U:G mismatch may be recognized by
the mismatch repair (MMR) machinery consisting of MSH2/MSH6 molecules which
physically recognizes the U:G mismatch bulge in the double helix, again resulting in the
recruitment of downstream nucleases and excision of bases surrounding the U:G lesion.
Under normal circumstances these lesions would be filled by high fidelity polymerases
leading to repair back to the original unmutated sequence. Through mechanisms that are
not yet understood, AID-induced mutations within germinal centre B cells are acted upon
by error-prone polymerases. Through these mechanisms the initial C to U conversion by
AID can ultimately result in the full range of mutations on any of the four nucleotides to
any of the other three possible nucleotides (Chaudhuri & Frederick, 2004; euberger et
al.,2005).
Examining the profile of SHM mutations in UDG.f- or MSH2.f- cell lines as well
as mice showed that the pattern of mutations were consistent within these 2 pathways
acting downstream of AID and the processing of AID and UDG generated lesions as
described above (Chaudhuri & Frederick, 2004; Neuberger et aI., 2005). Further support
that AID acts as a DNA mutator came from studying UNG. UNG is responsible for
excising U from the 0 A backbone and was found to act downstream of AID.
Furthermore, downregulating UNO limits CSR while knocking out both UNO and
MSH2, a mismatch repair protein, and eradicates both SHM and CSR (Rada, Di Noia, &
Neuberger, 2004).
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Figure 4. The DNA deamination processes of Somatic Hypermutation (SHM).
Figure 4. The DNA deamination processes of Somatic Hypermutation (SHM).
The process of SHM is proposed to occur in two phases. The first phases being the
deamination ofC to U by AID generating a U:G mismatch pairing which can have three
potential outcomes: i) replicating over the U:G mismatch pairing leads to a transition
mutation (Phase lA SHM); ii) the U:G mismatch pairing can be subject to uracil excision
by UNG creating an abasic site leading to either a transition or transversion mutation
(Phase IB SHM); or iii) the U:G mismatch pairing is recognized by MMR machinery
generating an A:T mutation (Phase 2). The abasic site created by UNG excising the U
residue may act as a substrate for APEI leading to a nick in the DNA strand. This DNA
nick can be repaired by the BER pathway or processed by non-homologous end joining
(NHEJ) resulting in CSR.
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1.6 AID is a member of the APOBEC family of cytidine deaminase enzymes
AID is a member of the Apolipoprotein B mR A-editing, enzyme-catalytic
polypeptide-like family (APOBEC). The AID/APOBEC family members deaminate
cytidine (in R A) or deoxy-cytidine (in D A) to uracil thus generating mutations in
either D A or RNA. The AID/APOBEC family has eleven members found in humans:
AID, APOBEC-I, -2, -3 (A to H) and -4 (Navaratnam et al., 1993; Teng et al. 1993). The
first family member identified was APOBECI, an enzyme expressed in the human small
intestine. The family is thus named because APOBECI edits the apolipoprotein B
(ApoB) pre-mRNA by converting a glutamine codon, more specifically deaminating a
cytidine at position 6666, into a stop codon generating a truncated form of ApoB
(Navaratnam et al., 1993; Teng et al., 1993). Other family members within the
AID/APOBEC family, such as the APOBEC3s, act as D A mutators. These are involved
in restricting retrovirus reproduction with the capability of limiting endogenous
retroelements as well (Liddament et al., 2004; Sheehy et al., 2002; Simon et al., 2005).
Besides AID, APOBEC3G (A3G) and APOBEC3F (A3 F) have also been the subject of
intense investigation because of their ability to mutate and act as restriction host factors to
the HIV-I genome. A hallmark of AID, A3G and A3F is their preference for
deaminating the 3' cytidines in specific trinucleotide motifs (Sheehy et al., 2002). These
trinucleotide motifs include CCC, TIT or WRC (W=NT, R=NG) (Conticello et al.,
2005). This sequence specificity is an inherent property of these enzymes reflecting their
footprint in vivo (Coker & Petersen, 2007; Larijani et al., 2005; Pham et al., 2003).
Currently the functions of APOBEC2 and APOBEC4 have not been characterized. Thus
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far, only the structures of APOBEC2 and the catalytic domain of A3G have been resolved
(Chen et aI., 2008; Prochnow et aI., 2007).
1.7 Structural features and enzvmatic properties of human AID
The structure of AJD has not yet been determined largely due to difficulties with
its purification to homogeneity. However, sequence homology between AJD and other
APOBEC members have allowed for identification of putative domains and important
residues necessary for its function (Figure 5). Among the functional domains identified
thus far are a putative nuclear localization signal (NLS) and dimerization domains found
within the N terminus, a zinc-coordinated catalytic site and a terminal carboxyl region
with both an APOBEC-like domain and a nuclear export signal (NES) (Barreto & Magor,
2011). It has been suggested that AJD forms a quaternary structure, like other
AJDIAPOBEC family members (Holden et aI., 2008; Prochnow et aI., 2007). This notion
was further supported by the discovery of a dirnerization domain between residues 46-53
and the findings that when mutations were made within this region a decrease in cytidine
deaminse activity was observed (Prochnow et aI., 2007). The putative catalytic domain is
located in the middle of the enzyme ranging from positions 56-90 and is characterized by
the H[AV]E-X[24_3WPCXXC motif (x: any amino acid). Based on homology with other
deaminases it has been suggested that histidine (H) and two cysteines (Cys) together with
a zinc cation fonn the catalytic core of the enzyme (Conticello, 2008). The zinc atom
together with a nearby glutamate, acting as a proton donor, coordinates the deamination
of the bound C to U by releasing a water molecule and the ammonium group from the
fourth carbon atom of the C (Conticello, 2008). Our structural modeling of AID based on
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the solved structure of the catalytic domain of A3G as well as our mutagenesis studies
(Dancyger et aI., 2011) support this model of deamination catalysis (Chen et aI., 2008;
Holden et aI., 2008). Within the carboxyl terminus of AID, the APOBEC-like domain
can be found between residues 119-183, this is another noted similarity to APOBECI due
to its homology and alignment; however it remains largely uncharacterized (Barreto &
Magor,2011). A ES at position 183-198 has also been identified. ES together with
NLS and the many hydrophobic residues within the carboxyl terminus may help to
explain why AID shuttles between the nucleus and the cytoplasm. These hydrophobic
residues have been proposed to exclude AID from the nucleus and help to explain AIDs
localization in the cytoplasm (Barreto & Magor, 2011; Rada et aI., 2004).
Our laboratory has previously described the enzymatic characteristics of human
AID and observed several unique features such as slow catalytic rates and high affinity
binding to ssDNA (Larijani et aI., 2007). We suggested that these attributes fit well with
the in vivo functions of AID in that they limit its genome-wide mutating activities. In
addition, these observations may explain the enzymatic processivity of AID in vitro
(Coker & Petersen, 2007; Pham, Chelico, & Goodman, 2007). We proposed that the
enzymatic properties of AID are important determinants of its biological functions.
Support for this notion has been provided by recent studies of human AID mutants that
showed altered catalytic rates and/or WRC specificity in vitro, and a corresponding
change in the pattern of activity in vivo (Kohli et aI., 2010; Wang et aI., 2009; Wang,
Rada, & Neuberger, 2010).
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Figure 5. A schematic representation of AID.
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Figure 5. A schematic representation of AID.
A to date schematic representation of the AID motifs (boxes above) and residues (listed
below) currently identified. In the N terminus, a putative nuclear localization signal
(NLS) and a dimerization domain, characterized by the H[AV]E-X[24_3WPCxxC motif (x:
any amino acid) have been characterized. A zinc-coordinated catalytic site was
discovered flanked by the N and carboxyl terminal regions. The carboxyl terminus was
found to have an APOBEC-like domain and a nuclear export signal (NES).
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1.8 Evolution of AID amongst species
The Gnathosotomata Uawed vertebrates) superclass of vertebrates are the first
species to show primary and secondary antibody diversification through V(D)J
recombination and SHM. Since then, these processes have been shown in a variety of
species including fish, frogs, lizards, birds and mammals (Barreto & Magor, 2011; Flajnik
& Kasahara, 2010; Pancer & Cooper, 2006). Although Chondroichthyes (cartilaginous
fish), such as sharks, are the earliest class of jawed vertebrates known to carry out SHM
and thus possess AID, Osteichthyes (bony fish) are to date the earliest species identified
to express full-length AID (Flajnik & Kasahara, 20 10). Of the teleost fishes examined,
AID from each of the pufferfish fugu (Takifitgu rubripares), zebrafish (Danio rerio) and
catfish (Ictalurus punctatus) have been examined and studied for functionality by
transfection into AID.f- primary B cells and/or non-Iymphocyte cell lines (Conticello et
aI., 2005; Conticello, 2008; Saunders & Major, 2004). Previous studies found that these
bony fish are able to mount an effective adaptive immune response but are unable to
undergo CSR, a mechanism that diverged after bony fish (Barreto et aI., 2005). Bony fish
can perform affinity maturation but it appears to be carried out in cell clusters that are
distinct from mammalian germinal centers (Saunders et aI., 2010). Furthermore, while
fish can change isotypes, this does not appear to be mediated by AID and is instead
initiated by an alternative form of V(D)J recombination (Danilova et aI., 2005; Hansen,
Landis, &Phillips, 2005). Interestingly, fish AID can rescue CSR in AID-1- B cells despite
a lack of CSR in these organisms, suggesting that AID gained this function prior to the
evolution of mammals (Barreto & Magor, 2011). The region of AID that is least
conserved among these lower vertebrates is the catalytic domain with each teleost having
eight or nine extra residues within the zinc-coordinating motif as compared to higher
order species (Barreto & Magor, 2011; Conticello et aI., 2005).
AID has also been identified in amphibians like the frog (Xenopus tropicalis),
Iberian ribbed newt (Pleurodeles waIt!) and the clawed toad (Xenopus laevis), all of
which are able to produce a diverse antibody repertoire (Bascove & Frippiat, 20 I0; Zhao
et aI., 2005). The type and extent of SHM and CSR in amphibians is currently not well
characterized although it does appear that they are the first species to carry out bona flda
CSR (Bascove & Frippiat, 2010; Mussmann et aI., 1997; Stavnezer & Amemiya, 2004).
Studies have found that these amphibians possess DOYW tetramer SHM motifs within Ig
S regions, such as AOCT (D= AlOfT, Y=C/T and W=A/T) demonstrating a preferred
D A target site for AID binding. SHM induced affinity maturation is rather poor in these
species however, antibody gene rearrangement mimics that of mammalians, with AID
sharing a similar gene and protein structure to higher order vertebrates (lchikawa et aI.,
2006; Mussmann et aI., 1997; Ohtani, Miyadai, & Hiroishi, 2006). While X laevis is able
to undergo CSR, this process is impaired in P. waltl (Ohtani, Miyadai, & Hiroishi, 2006),
this significant difference in activity between the two species is worthy of further
investigation.
Mammalian and bird species have the closest adaptive immune systems to
humans. Species whose AID sequence has been identified include mouse, rat, chicken,
duck, rabbit, dog, cat, cow, chimpanzee and human (Barreto & Magor, 2011; Bascove &
Frippiat, 2010; Zhao et aI., 2005). Amongst land dwelling tetrapods, the AID sequence
appears to be more highly conserved. This is highlighted by the conservation of all 15
residues whose mutations in humans can lead to Hyper-IgM syndrome among chicken
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and mammalian species (Zhao et aI., 2005). This suggests an important structure-
function relationship with respect to the primary sequence of AID.
1.9 Purpose ofthis study: discovering the structure function relationships
within Am
Rationale:
Since its discovery in 1999, much has been revealed about AID however, major
gaps regarding our understanding of the enzyme still exist. Specifically, details
concerning AID's mechanism of action, the importance of its properties, the specific
domains/residues responsible for initiating these effects as well as the enzyme's
evolutionary context remain unknown. As mentioned above, previous work has
identified the slow catalytic rate and high affinity binding of human AID to ssD A
(Larijani et aI., 2007). It was suggested that these biochemical and enzymatic
characteristics fit well with the in vivo functions of AID in that they explain its enzymatic
processivity and means to limit genome-wide mutating activities. In part because the
structure of AID has not yet been solved, two underlying questions will be examined:
first, what are the roles of individual domains and/or residues responsible for the
biochemical properties of AID? Second, what is the relationship between the different
properties of AID? For instance, it is not understood how differences in ssDNA binding
influence enzymatic activity.
One approach to gain insight into these issues is a comparative study of the
biochemical properties of AID from different species. We reasoned that differing AIDs
likely possess altered biochemical properties due to the biological and evolutionary
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divergence between organisms. These may include homeothermy versus poikilothermy,
possible variances in the cellular context of affinity maturation, and the types and extent
of secondary antibody diversification processes that are present in these organisms (i.e.
SHM and CSR) (Saunders et aI., 2010). Our approach is based on observation that AID
is highly conserved in mammals, birds and amphibians suggesting an intimate structure-
function link (Barreto & Magor, 2011). On the other hand, bony fish AID are the most
divergent from their human counterpart and therefore we hypothesized that these are
likely to have different biochemical properties (Barreto & Magor, 20 11; Conticello et aI.,
2005; Wakae et aI., 2006). Characterizing the distinct biochemical properties of AID
from divergent species and identifying the mechanisms of these differences can shed light
on the molecular basis of the biochemical parameters of AID.
Several earlier studies have examined the functionality of AID from pufferfish
fugu (Takifugu rubripares), zebrafish (Danio rerio) and channel catfish (lctalurus
punctatus). These studies showed that fish AID are capable of supporting SHM and CSR
when expressed in bacteria and cell lines (Barreto et aI., 2005; Barreto, Ramiro, &
ussenzweig, 2005; Ichikawa et aI., 2006; Wakae et aI., 2006). Others have
demonstrated that bony fish AID displayed differences in the levels of mutation and/or
CSR activity when compared amongst them and to human AID, suggesting that these
AID enzymes may have inherent catalytic differences between species. However, these
earlier studies used bacterial systems in which AID mutations create antibiotic resistance
and in eukaryotic cell lines where GFP reversion is measured as a function of AID-
mediated mutations. These experiments have examined the functionality of fish AID ex
vivo yet no direct structure-function information has been gained due to several
limitations of the experimental systems. First, the presence of multiple downstream DNA
repair pathways that process AID-mediated deaminations can alter the levels and spectra
of final mutations; second, the effect of varying conditions (e.g. temperatures) on
bacterial or eukaryotic cell growth may unequally influence the catalytic efficiencies of
different AIDs; third, disparity in the D A substrates (e.g. transgenes and their
integration sites, specific bacterial genes, immunoglobulin genes) used to quantify AID
activity can influence the efficiency of AID activity; and fourth, discrepancies in the
expression levels and/or solubility of various AIDs in the bacteria or eukaryotic cells
could result in differences in mutational activity.
To directly compare AID of bony fish and humans in a quantifying manner, we
have utilized a cell-free system to characterize the biochemical properties of purified AID
from bony fish in parallel with human AID in order to relate differences in their
properties to differences in their primary amino acid sequences. We report that purified
AID from dissimilar species have inherently diverse deamination efficiencies, that the
catalytic rates of bony fish AID are cold adapted, and that these discrepancies are
mediated through variable ssD A binding that is influenced by a single residue in the
carboxyl terminus.
Objective 1: To determine the roles of individual domains and/or residues responsible for
the biochemical properties of AID.
Objective 2: To detennine the relationship between different properties of AID, such as
ssDNA binding and enzymatic activity.
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2. Materials and Methods
2.1. Plasmids and constructs use for AID expression
EcoRJ fragments encoding the ORF of lp-AID and Dr-AID were cloned into the
pGEX-5x-3 vector (GE Healthcare, Baie d'Urfe, Quebec, Canada), a Glutathione S
transferase (GST) gene fusion vector used for detection and purification of GST fusion
proteins in bacteria, to generate GST-AID expression constructs analogous to the Hs-AID
which we have described (Larijani et aI., 2007; Saunders & Major, 2004; Zhao et aI.,
2005). These constructs were used as templates for gene-SOEing PCR to generate
hybrid AID molecules using primers that contained dual complementarity overlapping at
the junctions (Figure 6; arrows). Point mutants of lp-AID were generated using standard
PCR site-directed mutagenesis.
2.2 Site directed mutagenesis
Site directed mutagenesis was performed to generate H-AID G164D. The reaction
was done in duplicate for accuracy. MilliQ H20 was mixed with 10111 High Fidelity 5X
PCR buffer, 1.5111 10mM dNTP mixture, 125ng of H-AID GI64D primer
(CTTTCAAAGCCTGGGAAGACCTGCATGAAAATTCAG), 125nl of H-AID G 164D
compliment primer (CTGAATTTTCATGCAGGTCTTCCCAGGCTTTGAAAG), 25ng
of pGEX-5x-3 GST H AID plasmid and 1111 of High Fidelity DNA Polymerase (New
England BioLabs, Pickering, Ontario, Canada) to a total volwne of 50111. After a hot start
at 98°C for I minute, 30 cycles of a 3 step PCR (98°C for 30 seconds, 50°C for 45
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seconds and nOc for 6 minutes) was followed by nOc for 10 minutes. The samples were
held at 15°C for I hour and stored at 4°C overnight. The following morning 1111 of the
restriction endonuclease DP I was added and the reaction was incubated at 37°C for 2
hours. An aliquot of 45111 of the PCR product was pipetted onto membrane filters
(Millipore, Etobicoke, Ontario, Canada) suspended in MilliQ H20 and left undisturbed
for 1 hour at room temperature to remove unwanted salt, transferred to clean, labelled
1.5ml tubes and spun in a SpeedVac Concentrator (Savant, Napean, Ontario, Canada) to
remove excess water. A 5~d aliquot of the 5 Kb PCR product was added to 100111 Top 10
DH5a cells (Invitrogen, Burlington, Ontario, Canada). The reaction was gently mixed and
incubated on ice for 25 minutes. The reaction was then heat shocked at 42°C for 1 minute
and 30 seconds and placed back on ice. To the reaction, 200111 of Super Optimal broth
with Catabolite repression (SOC) media was added and the culture was shaken at 37°C
for 1 hour. After incubation, a 250111 aliquot of the culture was plated on Lysogeny broth
(LB) ampicillin (37g LB + agar, lL MilliQ dH20, 100llg/ml ampicillin) and incubated at
37°C overnight. The following day, five colonies were selected and grown in 5ml LB
medium with 50mg/ml ampicillin culture at 37°C and left to grow overnight,
approximately 18 hours. Each culture was centrifuged and the pellet collected in a 1.5ml
tube. The plasmid DNA was then purified using a QIAprep Spin Miniprep Kit (Qiagen,
Toronto, Ontario, Canada). A restriction digest using EcoRl and sequencing was
performed to verify the products had been cloned into the vector and that the inserts were
of the correct orientation (Larijani et aI., 2007).
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2.3 AID protein production and purification
Prior to protein purification, 1111 of GST-AID DNA was added to 50111
Escherichia coli BL21 (DE3) cells. The reaction was gently mixed and incubated on ice
for 25 minutes, followed by heat shock at 42°C for I minute and 30 seconds and then
placed back on ice. To the reaction, 200111 of SOC media was added and the culture was
shaken at 37°C for I hour. After incubation, 100111 of the culture was plated on LB
ampicillin (37g LB + agar, IL MilliQ dH20, 1001lg/ml ampicillin) and incubated at 37°C
overnight. The following day, one colony from each plate or a sterile loop of a glycerol
stock, approximately 5111, was selected and grown in 250ml LB medium with 50mg/ml
ampicillin culture, at 37°C and left to grow to log phase in an orbital shaker (Forma
Scientific, Marietta, Ohio, USA). To induce protein production 1mM isopropyl-P-D-
thiogalactopyranoside (IPTG) and 50mg/rnL of ampicillin were added. The culture was
incubated at 16°C overnight, approximately 16 hours, in a PsycroTherm Controlled
Environment Incubator Shaker. The culture was poured into a 250rnl algene
polypropylene bottle and centrifuged at 3836g for 20 minutes at 4°C in a Sorvall
Evolution RC Ultra Centrifuge. The supernatant was drained and the pellet was re-
suspended in 20mL of ice cold IX PBS. The re-suspended pellet was placed in a 50mL
falcon tube.
Cells were lysed in a French pressure cell press (Thermospectronic, Napean,
Ontario, Canada) twice, washing the cylinder with ice cold IX PBS in between each
cycle. The sample was transferred to a Nalgene polypropylene falcon tube and
centrifuged at 3836g for 10 minutes at 4°C in a Sorvall Evolution RC Ultra Centrifuge.
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The supernatant was purified on Glutathione sepharose beads (Amersham, Baie d'Urfe,
Quebec, Canada) and the protein was eluted as per the manufacturer's recommendations.
Multiple fractions, approximately 15 - 30, of 500!!l of eluted GST fusion protein were
aliquoted into clean, labeled 1.5ml tubes kept on ice. The optical density (OD) of each
collected fraction was measured using a nanodrop (Thermo Scientific, Napean, Ontario,
Canada) at 260nm and 280nm to detennine concentration and purity. Aliquots with a
protein concentration greater than Img/ml were pooled and dialyzed against IL of buffer
(20mM Tris-HCl, pH 7.5, 100mM NaCl, and I mM OTT) using SnakeSkin® Pleated
Dialysis Tubing (Thermo Scientific, Napean, Ontario, Canada) overnight, approximately
16 hours. The following morning, new dialysis buffer was added and the protein was left
to dialyze for an additional 3 to 5 hours. Aliquots of 20 - 50!!l of purified protein were
dispensed into clean, labelled 1.5ml tubes kept on ice. The protein was dipped in liquid
nitrogen for 30 seconds and stored at -80°C. Each batch of GST fusion protein was
purified in parallel and prepared 3-4 times independently for accuracy. Protein expression
levels, purity and concentration were quantified and equalized by sodium dodecyl suifate
polyacrylaminde gel electrophoresis (SOS PAGE) using bovine serum albumin (BSA)
standard and Coomasie blue staining. AID proteins were assayed for activity and complex
formation using deamination assays and electrophoretic mobility shift assays (EMSA) to
ensure acceptable integrity of the purified proteins (Larijani et aI., 2007).
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2.4 Substrate preparation
Three bubble substrates containing a single-stranded target region 7 nucleotides
long were generated. All the oligonucleotides used in cleavage and binding assays were
prepared by Integrated DNA Technologies (Toronto, Ontario, Canada) and were 56 base
pairs long. The top strand (BHagtop) was desalted while the bottom strands (TGCbub7,
TACbub7, AGCbub7) were HPLC purified. The three bottom strands TGCbub7,
TACbub7, AGCbub7 only differed from each other by the two nucleotides before the
target cytidine. The sequences of these strands are shown below with the target cytidine
highlighted with an asterisk (*):
BHagtop:
5'-AGA TCC TGC CCC GGC ACT TCG CCC GGG TTT TTC CAG TCC CTT CCC
GCT TCA GTG AC- 3'
AGCbub7:
5'-GTC ACT GAA GCG GGA AGG GAC TGT GAG C*TT CCG GGC GAA GTG
CCG GGG CAG GAT CT-3'
TACbub7:
5'-GTC ACT GAA GCG GGA AGG GAC TGT GTA C*TT CCG GGC GAA GTG
CCG GGG CAG GAT CT-3'
TGCbub7:
5'-GTC ACT GAA GCG GGA AGG GAC TGT GTG C*TT CCG GGC GAA GTG
CCG GGG CAG GAT CT-3'
To label the oligonucleotides 41lL of autoclaved MilliQ dH20, I III 10X PKN
buffer, 2.5pmol/1l1 of the bottom strand, 151lCi/lll ATP_[y_32p] and Illl ofPNK enzyme
were mixed and incubated at 37°C for 53 minutes followed by 65°C for 10 minutes to
deactivate the PNK enzyme then returned to 4°C. The reaction was quickly centrifuged
and 10!!1 of TE buffer was added. The 20!!1 reaction is added to a mini Quick Spin
Column (Roche, Laval, Quebec, Canada) and spun at 393.12g for 3 minutes to remove
any unlabelled oligonucleotides. The fmal volume was adjusted to SO!!I by adding S!!I
IM KCI, 3!!1 2.Spmol/!!1 top strand and autoclaved MilliQ H20. The reaction was mixed
and incubated at 96°C for 2 minutes. The incubation temperature decreased by 1°C every
minute until 82°C was reached, then decreased by 1°C every 30 seconds to 3SoC and
finally decreased by 2°C every 30 seconds to 6°C. The labeled reaction tube was stored at
-20°C. A typical substrate with the WRC motif TGC in a 7 nt bubble (TGCbub7) is
shown in Figure 8 (Larijani et aI., 2007).
2.5 Deamination assay
The deamination assay was used to quantify the enzymatic activity of pure AID.
Labelled substrate, ranging in concentration of O.IS to SOfmol, was incubated with 0.1 to
0.2S!!g of GST-AID in 100mM Phosphate buffer pH 7.28 to a total volume of 10!!1, for
time periods ranging from 30 minutes to 3 hours at ISoC, 18°C, 2SoC or 37°C. For time
sensitive or activity sensitive reactions, AID was deactivated at 8SoC for 20 minutes and
37°C for 10 minutes. The volume of the reaction was increased to 20!!1 by adding 7.8!!l
autoclaved MilliQ H20, 2!!1 10X UDG buffer and 0.2!!1 UDG enzyme (New England
BioLabs, Pickering, Ontario, Canada). A 30 minute incubation period at 37°C followed to
excise the uracil generated by the deamination of the target cytidine. Finally, 200mM
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aOH was added and the sample was heated to 95°C for 10 minutes to cleave the alkali-
labile abasic site in the D A backbone. Formamide loading dye (lOlll of95% formamide,
0.25% Bromophenol Blue) was added to the samples which were heated again to 95°C for
10 minutes. Samples were electrophoresed at room temperature on a 14% denaturing
acrylamide gel (IX TBE, 25% Formamide, 14% acrylamide:bisacrylamide [19:1], 7M
Urea) with a running buffer of IX Tris-Borate-EDTA (TBE) at 300 - 350V for 2 - 3
hours. The gels were exposed to a Kodak Storage Phosphor Screen GP (BioRad,
Mississauga, Ontario, Canada) overnight, for approximately 18 hours, and visualized
using a PhosphorImager (Molecular Dynamics, Sunnyvale, California, USA) (Larijani et
al.,2007).
2.6 Electrophoretic mobility shift assay
The electrophoretic mobility shift assay (EMSA) was used to quantify the
enzyrnatic binding affinity of pure AID. Labelled substrate, ranging in concentration from
O.IS to SOfinol, was incubated with 0.1 to O.251lg of GST-AID in EMSA binding buffer
(50mM Tris, pH 7.5, 21lM MgCI, 50mM NaCI, and ImM DTT) in a final volume of 10111
for time periods ranging from 2 - 3 hours at 18°C, 2SoC or 3SoC. Samples were optimally
UV crosslinked (Stratagene, Santa Clara, California, USA) on ice, twice. Samples were
electrophoresed at 4°C on an 8% native gel (6% glycerol, 8% acrylamide:bisacrylamide
[19:1], O.SX TBE) with a running buffer ofO.SX Tris-Borate-EDTA (TBE) at 300 - 350V
for 2 - 3 hours. The gels were dried on chromatography paper (Whatman, Kent, United
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Kingdom), exposed to a Kodak Storage Phosphor Screen GP (BioRad, Mississauga,
Ontario, Canada) overnight, for approximately 18 hours, and visualized using a
Phosphorlmager (Molecular Dynamics, Sunnyvale, California, USA) (Larijani et aI.,
2007).
2.7 Data coUection and quantification of data
All quantifications were done using Quantity One I-D Analysis Software
(BioRad, Mississauga, Ontario, Canada). Data from deamination assay gels were plotted
as substrate and product fractions. Data from EMSA gels were plotted as bound and free
fractions of the substrate. Deamination assay gels and EMSA gels were quantified 2-3
times independently by two people and the results were averaged. Sister repeated gels
were averaged thus obtaining an average value for the lane. This single data point
represents the mean of the values obtained in this manner from all experiments. Graph
averages represent 4-6 independent experiments. Error bars represent the standard
deviation between independent experiments and are not a range of values in one
experiment but the range across all parallel experiments. The data were graphed using
GraphPad Prism Software (La Jolla, California, USA).
Densitometry was done using Quantity One I-D Analysis Software (BioRad,
Mississauga, Ontario, Canada). Deamination or EMSA gels contained duplicate
independent reactions for each AID: substrate combination. Experiments were repeated
5-12 times to ensure that all independent AID purifications where all species variants,
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hybrid enzymes and mutants were purified in parallel were represented. For each
experiment, an individual lane of an alkaline cleavage or EMSA gel was quantified 3
times, thus obtaining an average value for the lane, representing a single data point
(typically the triplicate measurements of each lane as well as the duplicate reaction lanes
within each experiment contained a variability of < 5%). The data points on the graphs
are the mean of the values obtained in this manner from all experiments (5-12
experiments yielding 10-24 values for each data point). Error bars represent standard
deviation between independent experiments. The data were graphed using GraphPad
Prism Software (La Jolla, California, USA).
2.8 Statistical analvsis
Statistical significance of differences between the activity levels of two types of
AID was ascertained by performing analysis of variance and two- tailed student tests.
Data from all experiments were compared (typically n=10-24). Analysis was performed
using GraphPad Prism Software (La Jolla, California, USA).
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3. Results
3.1. The catfish AID sequence is most divergent from other AID species
Cartilaginous and bony fish are the earliest species to express AID (Barreto &
Magor, 2011; Flajnik & Kasahara, 2010). While AID is necessary for both CSR and
SHM, the earliest evidence of CSR only appears after the divergence of bony fish, from
amphibians onward. Bony fish are able to mount an effective adaptive immune response
but unable to undergo CSR (Barreto et aI., 2005; Barreto & Magor, 2011; Conticello et
aI., 2005). In order to identify the species which possesses the most divergent form of
AID from humans, we aligned the published sequences of representative organisms from
various classes throughout evolution including: Osteichthyes (bony fish), Amphibia,
Aves, and Mammalian. Figure 6 displays the sequence alignment of bony fish fugu
(Ta/..:ifugu rubripes, Tr-AID), channel catfish (lctalurus punctatus, lp-AID) and zebrafish
(Danino rerio, Or-AID), with xenopus (Xenopus laevis, Xl-AID), chicken (Gal/us gal/us,
Gg-AID), human (Homo sapiens, Hs-AID) and mouse (Mus musculus, Mm-AID).
Residues underlined in blue indicate those that are identical between species, residues
underlined in green identify amino acids within a similar group while those underlined in
red indicate unlike residues. Comparing the various forms of AID from bony fish to
amphibians to birds to mammals our results show, in agreement with previous work, that
AID is a relatively conserved enzyme over evolution possessing a high proportion of
identical and similar residues (Barreto & Magor, 2011). The three domains of the
enzyme, the N-, catalytic, and carboxyl terminals, are shown using arrows (Figure 6).
Among chicken (Gg), mouse (Mm) and human (Hs) AIDs, there is a remarkably high
level of conservation with chicken (Gg) and mouse (Mm) having seven and eight non-
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similar residues to Hs-AID, respectively. Less residue preservation is seen between
xenopus (Xl) and bony fish (Tr, Ip and Dr). The AID sequence in bony fish does include
extra residues in all 3 termini, with the most being present in the catalytic domain,
indicating that over time the enzyme has deviated from its ancestral form.
To gain additional perspective, a residue identity and similarity analysis was
conducted where the percentage of residues that were identical and similar in various
species were compared to its human counterpart. Figure 7 shows the catalytic domain of
Seryl tRNA synthetase, a housekeeping enzyme, weighed against RAG-I/2, an enzyme
involved in the generation of primary antibody diversity, and AID (left, middle, and right
panels respectively) where each point in the graph represents the emergence millions of
years ago (mya) of the species mentioned above. In agreement with its function in vivo,
Seryl tRNA synthetase shows little divergence over evolution. RAG-I/2 and AID, which
are enzymes involved in diversity generation in the immune system are thus under
heightened evolutionary pressure, show much greater residue variance over time.
Amongst the land species human (Hs), mouse (Mm) and chicken (Gg) AID were found to
be more highly conserved compared to RAG-1I2 (96% vs. 74% similarity). In contrast, a
notable level of deviation, as seen by the drastic drop in amino acid similarity and
identity, was observed between zebrafish (Dr) and pufferfish (Tr) as compared to channel
catfish (Jp) AID with the latter being considerably less conserved with Hs-AID (126 and
128 versus 126 identical residues). Unlike AID, neither Seryl tRNA synthetase nor RAG-
1/2 showed the same level of divergence between the three bony fish. From these results,
it was concluded that amongst bony fish AID, Ip-A1D was the most divergent form from
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its human counterpart. Therefore, we hypothesized that is may possess altered enzymatic
and biochemical characteristics.
Figure 6. Sequence alignment of AID from representative species across classes.
Figure 6. Sequence alignment of AID from representative species across classes.
The comparison of AID sequences from representative species across classes. Residues
are colored according to side-chain. Blue, green and red underlines indicate identical,
similar and unlike residues respectively. Arrows denote the borders of the -, catalytic
and carboxyl domains. The sequence alignment is based on the published
sequences of AID (Mus musculus: NP033775, Homo sapien: AAM95406.1, Gallus
gallus: XP4l6483,Xenopus laevis: NPOO1089l81, Ta/djugu rebripes: AAU95747, Danio
rerio: NPOOI008403, lctalurns punctatus: AAR7544).
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Figure 7. Percent identity and similarity between 3 human enzymes.
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Figure 7. Percent identity and similarity between 3 human enzymes.
The percent of amino acid identity or similarity between 3 human enzymes and their bony
fish counterparts. Based on the sequence alignment of the published sequences for Seryl
tRNA synthetase (Homo sapiens: BAA95602.1, Mus musculus: P034559.1, Gallus
gallus: POOI026563.1, Xenopus laevis: POOI080487.1, Danio rerio: BAI44434.1,
!ctalunls punctatus: AAY86956.1), RAG-I/2 (Homo sapiens: AAA60248.1, Mus
musculus: P033045.2. Gallus gallus: AAA49051.5 Xenopus laevis: AAX68652, Danio
rerio: 013033.1, lctalurus punctatus: ABG47664.1) and AID (as shown previously in
Figure 4). The left panel shows the sequence comparison of the essential house-keeping
enzyme, Seryl tRNA synthetase catalytic domain. The middle panel shows the sequence
comparison of RAG-I/2, an enzyme involved in antibody diversity. The right panel
shows the sequence comparison of A1D. Approximate periods of species emergence
(millions of years ago) are shown on the x-axis.
3.2 Differences in the activity levels of Hs-AID Or-AID and lp-AID
To measure the activity of bony fish and human AID, we used a previously
established in vitro experimental system where Hs-AID, Ip-AJD, and Dr-AID were
independently cloned into an expression vector, expressed in E.coli and column purified
to produce GST-tagged AlD (Larijani et aI., 2007). All three AlDs were expressed and
purified in parallel multiple independent times with similar AID yields. The amount of
AID used was equalized by semi-quantitative SDS PAGE. We used the previously
established alkaline cleavage assay to measure the enzymatic activity of each enzyme. In
this assay, AlD is incubated with the radioactively labeled bubble substrate (Figure 8).
We used a 7 nt bubble substrate containing various WRC motifs (AGC, TAC or TGC)
which were previously shown to be an optimal target for deamination by AID in vitro
(Larijani & Martin, 2007). AID converts the target C to U, the U is then removed by the
addition of UNG generating an abasic site which is alkali-labile (Larijani & Martin,
2007). Alkaline-cleavage at this site produces a cleaved product, the amount of which we
can use to accurately measure and quantify AID activity. We used partially single-
stranded substrates with a bubble of 7 nucleotides in length, which we previously found
to be an optimal substrate of AlD (Larijani & Martin, 2007).
Figure 9A shows the deamination activity of equal amounts of Hs-AlD, Dr-AJD
and lp-AID incubated with the TGCbub7 WRC substrate for one hour. We observed that
Hs-AlD and Dr-AlD mediated comparable levels of deamination (34 vs 28%).
Conversely, lp-AID appeared to have little to no activity, similar to levels of the negative
control which lacked AID. This observation was repeated using three independent
preparations of lp-AID starting with independently cloned expression vectors. To
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decipher if lp-AID was a catalytically-inactive enzyme or whether it was significantly
less active than AIDs from the other species tested, the incubation period of lp-AID with
the labeled bubble substrate as well as exposure time of the gel was increased. Figure 98
shows the overnight incubation and overexposed assay. The gel revealed that indeed Ip-
AID is not catalytically inactive, but rather has approximately one order of magnitude less
activity as compared with Hs-AID and Or-AID. Some catalytic activity is present in Ip-
AID, though very little (2.6%).
To compare the deamination kinetics of each AID enzyme, we measured the
production of deaminated product on the TGCbub7 substrate by Hs-AID, Dr-AID and lp-
AID as a function of time, ranging from 5 minutes to 420 minutes. The reaction was
terminated by initiating alkaline cleavage. As shown in Figure 10, with a representative
quantifying gel in the inset and consistent with our previous findings, Hs-AIO and Or-
AID exhibited robust enzymatic activity detectable at 5 minutes which increased linearly
for 1 hour (62 vs 56 finol product, respectively). In contrast, lp-AID produced very little
product (6 frnol) even after a prolonged period of incubation of 420 minutes, carrying out
the same level of deamination as seen by Hs-AID and Or-AID in 5 minutes. Considering
the amount of deamination in a given period of time and the length of time taken to
generate a set amount of deaminated product, we conclude that lp-AID is approximately
10 fold less active and therefore less efficient than both Hs-AID and Or-AID.
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*GTCACTGAAGCGGGAAGGGACTGT
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CAGTGACTT CGCCCT T CCCTGACTT TTTT.pGCCCGCT TCACGGCCC CGTCCTAGA
Figure 8. Typical substrate used in the in vitro alkaline cleavage activity assay.
Figure 8. Typical substrate used in the in vitro alkaline cleavage activity assay.
The target cytidine is indicated by the arrow and the radioactively labeled strand is
denoted by "*". Dinucleotide upstream of the target cytidine can be varied among
different substrates to generate a WRC or non-WRC motif.
48
A B
CL N c;;-a.. a..
0 0 0' 0' 0'
<i: <i: <i: ~ <i: 0ch CS .e- .e- ~I ~ ~
Substrate-
Product-
Figure 9. In vitro activity of human and bony fish AID.
Figure 9. In vitro activity of human and bony fish AID.
A. Oligonucleotide alkaline-cleavage assay showing the activity of human (Hs), zebrafish
(Or) and catfish (lp) GST-AID incubated with TGCbub7 substrate for 1 hour. Three
independently purified preparations of catfish GST-AID were tested, lp-AID (PI), Ip-
AID (P2), lp-AID (P3).
B. Activity of catfish GST-AID (lp-AID) in the alkaline cleavage assay upon prolonged
overnight incubation and over-exposure of the assay gel.
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Figure 10. Comparison of activity kinetics between Hs-AID, Dr-AID and lp-AID.
Figure 10. Comparison of activity kinetics between Hs-AID, Dr-AID and lp-AID.
The TGCbub7 substrate, 10 finol, was incubated with human (Hs), zebrafish (Dr) and
catfish (Jp) GST-AID for various times ranging from 5 to 420 minutes. The reactions
were subsequently terminated by initiating alkaline cleavage. Inset shows a typical gel
used to measure product generated at each time point and to calculate deamination
velocity.
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3.3 The activity of Or-AID and lp-AID are temperature-dependent
The assays described above were carried out at 37°C, the optimal temperature for
Hs-AID; however, the physiological temperatures for catfish and zebrafish are
approximately 14°C to 25°C. To test whether the catalytic activity of purified lp-AID and
Or-AID are adapted to lower temperatures, we carried out deamination assays on three
WRC substrates (TGCbub7, TACbub7 and AGCbub7) at ISoC, 25°C, and 37°C. Whereas
Hs-AID showed generally decreasing activity with decreasing temperatures, the
enzymatic activities of both lp-AID and Or-AID increased appreciably as the temperature
was decreased (Figure IlA and B). Regardless of temperature or substrate, lp-AID
activity levels were always lower than Hs-AID, only approaching it at ISoC (20% vs. 26%
for TGC and 5.7% vs. 7.4% for AGC). In contrast, Or-AIO was up to 4.S fold more
active than the highest level reached by Hs-AIO on the same substrate (SO% vs. 3S% on
TGC, 33% vs. 24% on TAC and 63% vs. 13% on AGC).
Given that Or-AID, lp-AID and Hs-AIO showed optimal activity under different
conditions, we tested the maximal enzymatic potential of each under its own optimal
conditions (Figure 12). Or-AID at 25°C exhibited the greatest velocity of product
formation reaching nearly twice that of Hs-AID at the point of maximal difference. In
agreement with our previous results, lp-AID was almost inactive at 37°C but gained
activity at lower temperatures of ISoC and 25°C with a velocity approaching at best half
that ofHs-AID. To examine if temperatures at lower than ISoC would further increase Ip-
AID activity the deamination kinetics of lp-AID were tested at 15°C; however, no
difference in activity was found in comparison to that of our results at IS°C. In
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conclusion, we found that at the points of maximal difference Or-AID was approximately
2 fold more active than Hs-AlO while lp-AID (at 2SoC or 18°C) was approximately 2 fold
less active than Hs-AID.
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Figure 11. Temperature and substrate preference of bony fish AID.
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Figure 11. Temperature and substrate preference of bony fish AID.
A. The activity of Hs-AID and lp-AID were compared on the three WRC substrates
(TGCbub7, TACbub7 and AGCbub7) at three difference temperatures, 37°C (top panel),
25°C (middle panel), and ISoC (bottom panel). Hs-AID reactions are shown on the left of
each gel, while lp-AID reactions are shown on the right. A negative control reaction is
also shown on each gel. Twenty fmol of substrate was incubated with GST-AID for I
hour.
B. The percent deamination products were quantified and plotted for each substrate and
temperature combination for Hs-AID, lp-AID and Or-AID. For TGCbub7, comparing
Dr-AlD to Hs-AID at ISoC: p=O.004; at 25°C p=O.OI; at 37°C p=O.OOI and comparing
Hs-AID to lp-AID at 25°C p=O.04. For AGCbub7, comparing Dr-AID to Hs-AID at
ISoC: p=O.004; at 25°C p=O.009; at 37°C p=O.02. For TACbub7, comparing Or-AID to
Hs-AID at ISoC: p=O.OOS; at 25°C p=O.02; at 37°C p=O.006.
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Figure 12. Comparison of deamination kinetics between Hs-AID, Dr-AID and Ip-
AID under optimal conditions.
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Figure 12. Comparison of deamination kinetics between Hs-AID, Dr-AID and Ip-
AID under optimal conditions.
The deamination kinetics of Hs-AID, Dr-AID and lp-AID were compared under their
optimal substrate (TGCbub7) and temperatures conditions. Reaction velocities are shown
as a function of substrate concentration over a 100 fold dilution range (0.025 - 2.5 nM).
Comparing Dr-AID (25°C) and Hs-AID (37°C) p=0.03, and comparing Hs-AID
and lp-AID (18°C) p=O.OI.
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3.4 The basis of the low activity of lp-AID at 31'C
Alignment of the AID proteins of our test species revealed considerable
divergence between the fishes and mammals, particularly when compared with the
divergence of another protein involved in adaptive immunity (RAG-I) or a housekeeping
protein (seryl-tRNA-synthetase; Figure 7). To determine if these differences might result
in gross structural differences in the enzymes, we modeled all three based on the
determined crystal structure of the catalytic domain of family member APOBEC3G
(Chen et aI., 2008; Holden et aI., 2008; Shandilya et aI., 2010). The progression of
domains from the N- to carboxyl-terminus is shown from blue to red in Figure 13.
Residues involved in the Zn-coordinating catalytic domain are shown as red sticks. For
Hs-AID, these include H56, E58, C87, C90. For Dr-AID, these include: H60, E62, C99,
CI02. For lp-AID these include: H59, E61, C98, CIO\. All three were predicted to form
the canonical APOBEC family arrangement of alpha helices surrounding a beta sheet,
with the catalytic (Zn-coordinating) residues forming a catalytic pocket that was
indistinguishable (Figure 13) (Conticello et aI., 2007). As we did not observe major
structural differences, we conclude that the disparity in activity is likely due to subtle
distinctions in amino acid residues.
Based on the placement of the Zn-coordinating catalytic residues and other motifs
identified in AID by homology to other deaminases, AID can be divided into three
segments: The N-, catalytic and carboxyl- terminals (see arrows in Figure 6). To
detennine which of the three domain(s) are responsible for the change of the lp-AID
lethargy at 37°C, gene-SOEing was used to construct various hybrid GST-AID enzymes
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where segments from each species were swapped. Linear representations of the hybrid
generated are displayed in Figure 14A. Figure 14B shows the test of the activities of the
various domain-swapped hybrid AID enzymes with TGCbub7 at 37°C. As previously
revealed in Figure 9, lp-AID shows little activity while Hs-AID and Dr-AID are potent
deaminators. Replacing the catalytic domain of Hs-AID with either the Dr (HDH) or Ip
(HIH) did not diminish AID activity at 37°C. In opposition, replacing the catalytic
domain of lp-AID with the Hs segment (IHI) did not rescue enzyme activity. These
experiments exclude the possibility that the catalytic domain of AID is responsible for its
deaminating ability. Interchanging the N terminus of lp-AID with the Hs portion (HII)
also failed to recover activity, ruling out the N terminus as well as solely being
accountable for the change in enzyme activity. However, substituting the carboxyl
terminus ofIp-AID with the Hs (I1H) rescued AID activity at 37°C. These results identify
the carboxyl terminus as responsible for the poor activity of lp-AID at 37°C.
Next, we sought to determine which residue(s) within the carboxyl terminus of
AID were specifically responsible for the rescued effect previously noted. Figure 15
shows an alignment of the carboxyl terminal domains of all three species. We identified
twelve residues (denoted by an asterisk) as being divergent in lp-AID from both Hs-AID
and Dr-AID. We mutated each of these residues to its Hs-AID equivalent. Thus, twelve
point mutants and a triple mutant (N 167H, Q 168E, A170T) were generated and tested for
activity at 37°C on all three WRC substrates (TGCbub7, TACbub7 and AGCbub7)
(Figure 16A). The deamination activity of each point mutation was quantified on each of
the three substrates. All the mutants demonstrated a preference for deaminating TGCbub7
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over AGCbub7 and to a lesser extent TACbub7. Interestingly only one mutant, lp-AID
D176G, rescued deamination activity to levels comparable to those seen in Hs-AID.
Figure 16B shows the rescue of lp-AID activity by the D 176G mutation. We conclude
that the poor enzymatic activity of lp-AID at 37°C is due to a single non-conservative
amino acid difference with Hs-AID and Dr-AID in the carboxyl-terminus.
To confirm this result we introduced the reverse mutation in Hs-AID. Figure 17
shows the deamination kinetics for Hs-AID, lp-AID, lp-AID 0176G and Hs-AID GI64G
with the TGCbub7 substrate at 37°C. We found that the 0176G mutation almost
completely rescued the velocity of lp-AID to levels of HS-AID at 37°C (0.39 vs 0.49
fmol/l!g AID/min), indicative of an almost complete recovery of enzymatic activity. We
confirmed that Hs-AID G 1640 had diminished enzymatic velocity at 37°C by 5.4 fold
(0.49 vs 0.09 finol/l!g AID/min). We note that this G is conserved in AID from all
species analyzed to date, with the exception of a few bony fish (including Tr-AID) that
like lp-AID have an acidic residue at this position (Figure 6, arrow) (lchikawa et aI.,
2006).
61
Hs-AID Or-AID lp-AID
Figure 13. Predicted structures orBs-AID, Dr-AID and lp-AID monomers.
Figure 13. Predicted structures of Hs-AID, Dr-AID and lp-AID monomers.
The predicted ribbon structures of human (Hs), zebrafish (Dr) and catfish (Ip) AID
monomers, modeled based on the published structure ofthe APOBEC3G catalytic region.
N to carboxyl-terminus progression is shown as blue to red. The putative Zn-coordinating
catalytic residues are shown as sticks in red (Hs-AID: H56, E58, C8?, C90; Dr-AID: H60,
E62, C99, CI02; lp-AID: H59, E61, C98, CI01).
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Figure 14. Analysis of hybrid AIDs.
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Figure 14. Analysis of hybrid AIDs.
A. Various hybrid GST-AIDs containing the N-, catalytic and carboxyl-terminus domains
from human (Hs), zebrafish (Or) and catfish (Jp) AID were constructed and tested for
activity. The three letter designation of each hybrid denotes the N-, catalytic and
carboxyl-terminus domains, respectively.
B. Alkaline cleavage assay showing the activity of lp-AID, Hs-AID, Or-AID and the
hybrid GST-AIDs. Twenty frnol of the TGCbub7 substrate was incubated with each
GST-AID for 1 hour at 37°C.
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Figure 15. Alignment of the carboxyl terminal of Hs-AID, Dr-AID and lp-AID.
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Figure 15. Alignment of the carboxyl terminal of Hs-AID, Dr-AID and lp-AID.
The twelve residues divergent in lp-AID from both Hs-AID and Dr-AID are denoted by
an "*". These residues were targeted for point mutation and mutated to their Hs-AlD
equivalent. In addition, a triple mutant (NI67H, Q168E, AI70T) was also generated. The
arrow denotes the lp-AID DI76G mutation that explains lp-AID lethargy at 37°C.
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Figure 16. The activity oflp-AID mutants.
Figure 16. The activity ofIp-AlD mutants.
A. The activity ofHs-AID, lp-AID and 13 lp-AID mutants were tested on the three WRC
substrates, TGCbub7, TACbub7 and AGCbub7 by alkaline cleavage assay. Fifty finol of
substrate was incubated with GST-AID for I hour and the percent deamination products
are plotted.
B. The deamination assay showing the rescue of lp-AID activity at 37°C by the DI76G
mutation. Twenty finol of TGCbub7 substrate was incubated with GST-AID for I hour
and the deamination assay is visualized.
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Figure 17. lp-AID D176G is identified as a rescue mutation.
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Figure 17. lp-AID D176G is identified as a rescue mutation.
The deamination kinetics comparing the product formation of Hs-AID, lp-AID D176G,
Hs-AID G164D and lp-AID using a substrate concentration ranging lOO fold (I finol to
100 finol). The TGCbub7 substrate was incubated with each GST-AID for I hour at
37°C. Comparing lp-AID and lp-AID (D 176G) p=0.009, and comparing Hs-AlD and Hs-
AID (Gl64D) p=0.008.
3.5 The effects ofG176D mutation on lp-AID activity
To examine the effects of the lp-AID 0176G and Hs-AID G1640 mutations on
sequence and temperature dependence we tested their activity on all three WRC
substrates, TGCbub7, TACbub7 and AGCbub7 and at all three conditions, 37°C, 25°C
and ISoC in comparison to Hs-AID and lp-AID (Figure IS, Figure 11). Ip-AlD 0176G
showed a temperature profile similar to that ofIp-AIO and Or-AID previously observed,
deaminating more efficiently at ISoC and 25°C rather than 37°C. 0176G was able to
increase the enzymatic efficiency ofIp-AID at all temperatures, displaying approximately
10 fold more activity at 37°C and 6 fold more activity at ISoC and 25°C. The activity of
lp-AID or 76G was 3.4 fold higher than Hs-AIO (at lSoC: 7S% vs 23% on TGCbub7 and
23% vs 7% on AGCbub7). Conversely, the Hs-AID GI640 reduced the activity of Hs-
AID only at 37°C. From these results we conclude that the 0 to G mutation has a
profound effect on lp-AID activity, increasing activity at 37°C to levels comparable to
Hs-AIO, and increasing activity at ISoC and 25°C to levels several fold higher than Hs-
AID, reminiscent of Or-AID. Thus, we sought to compare lp-AID G1760 and Or-AlD
directly.
Figure 19A shows a comparison of the deamination activities ofOr-A10, lp-AID
0176G, Hs-AIO and lp-AID on the preferred WRC substrate TGCbub7 (right panel) with
a linear representation of the enzymes (left panel). Remarkably, we found the activity
levels of Or-A10 and lp-AID 0176G and their temperature dependence profiles to be
identical. These results show that the 0176G mutation is a potent modulator of activity
and that this single residue divergence between Or-AID and lp-AID accounts for the
difference in their catalytic potential. However, the temperature preference pattern of lp-
AID remains unaltered by the mutation; therefore, this effect must also be dependent on
other residues.
The higher activity of lp-AID Dl760 as compared to Hs-AID at ISoC and 2SoC
suggests that residue(s) other than 0164 ofHs-AID exert an activity-suppressing effect at
lower temperatures. We postulated that these residues likely lie in the carboxyl terminus
since we observed that the velocity of lp-AID D1760, in which one residue was replaced
with its Hs-AID counterpart, was higher relative to that of Hs-AID as compared to IlH-
AID, in which the entire carboxyl-terminus was replaced with that of Hs-AID (Figure
17). To test this notion directly, we examined lp-AID 01760, IIH-AID and Hs-AID in
parallel (Figure 19B). We found IlH-AID was up to approximately 4-fold less active at
ISoC and 2SoC than lp-AID 01760. Thus, residue(s) other than 0164 in the carboxyl-
terminal domain ofHs-AID account for its reduced enzymatic activity.
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Figure 18. The effects of the DI76G mutation on lp-AID activity.
Figure 18. The effects of the D176G mutation on lp-AID activity.
The deamination activities of Hs-AID, lp-AID DI76G and Hs-AID GI64D were
compared on all three WRC substrates (TGCbub7, TACbub7 and AGCbub7) at 37°C,
25°C and 18°C. Twenty finol ofsubstrate was incubated with each GST-AID for 1 hour
and the percent of product formation was plotted. For TGCbub7, comparing lp-AID
0176 to Hs-AID at 18°C: p<O.OOOl, at 25°C: p<O.OOOl, at 37°C: p<O.OOOl. For TACbub7
comparing lp-AID DI76 to Hs-AID at 18°C: p=O.006, at 25°C: p=O.OI, at 37°C: p=O.02.
For AGCbub7 comparing lp-AID 0176 to Hs-AID at 18°C: p=O.007, at 25°C: p=O.002, at
37°C: p=O.02.
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Figure 19. Comparison of the deamination activities of various AIDs at 37·C, 2S·C
and IS·C.
A. A comparison of the deamination activities of Dr-AID, lp-AID D 176G, Hs-AID and
lp-AID on the TGCbub7 substrate at 37°C, 2SoC and IS°C. Twenty finol ofsubstrate was
incubated with each GST-AID for I hour and the percent of product formation was
plotted. The left panel shows the linear representation of these enzymes while the right
panel compares the deamination efficiencies of each at three temperatures, 37°C, 2SoC
and ISoC. Comparing Dr-AID/lp-AID G176D to Hs-AID at ISOC: p=O.003, at 2SoC:
p=O.OI, at 37°C: p=O.OOI.
B. A comparison of the deamination activities oflp-AID D176G, Hs-AID and IIH-AID
on the TGCbub7 substrate at 37°C, 2SoC and ISoC. The left panel shows the linear
representation of these enzymes while the right panel compares the deamination
efficiencies of each at three temperatures, 37°C, 2SoC and ISoC. Comparing lp-AID
DI76G and IIH-AID at ISoC: p=O.002, at 2SoC: p=O.009, at 37°C: p<O.OOOI.
3.6 The D176 residues in lP-AID suppresses DNA binding activity
We next examined how the DI76 residue exerts its effects on lp-AID activity. To
locate D176, we modeled the surface of Hs-AID, Dr-AID, and lp-AID based on the
resolved structure of the APOBEC3G catalytic unit (Figure 20) (Chen et aI., 200S;
Holden et aI., 200S; Shandilya et aI., 2010). All AID models show topology similarity to
APOBEC3G. The D 176 residue on Ip-AJD (G 177 on Dr-AID, and G 164 on Hs-AJD) was
located on the surface and proximal to residues in APOBEC3G that have been shown to
contact ssDNA (Figure II arrow, bottom right panel) (Chen et aI., 200S; Holden et aI.,
200S). To detennine if the DI76 residue on lp-AID leads to a reduction in ssDNA
binding, we examined ssDNA binding properties ofIp-AJD, Hs-AID and lp-AID D176G.
We used quantifYing EMSA that we previously developed to detennine the binding
affinity of Hs-AID to ssD A (Larijani & Martin, 2007; Larijani et aI., 2007). Figure 21
shows the half-saturation kinetics of AID and ssD A binding over a range of substrate
concentrations at ISoC, 2SoC, and 37°C. KJ values were derived using non-linear
regression analysis (Table I). For Hs-AID, the KJ values at the three temperatures were
similar (Table I: 0.10-0.31 nM). Although the KJ for lp-AID was similar to Hs-AID at
ISoC and 2SoC (Table I: 0.07-0.14 nM), the KJ for lp-AID was approximately 7-fold
higher than that for Hs-AID at 37°C (Table I: I. I nM vs. O.IS nM, respectively). These
values correlate well with the relatively comparable levels ofIp-AID and Hs-AID activity
at ISoC and 2SoC and with the severely diminished activity oflp-AID at 37°C. On the
other hand, Ip-AJD DI76G had KJ values that were 2 to 6-fold lower than Hs-AJD and
lp-AID at ISoC and 2SoC (0.03-0.0S nM range), consistent with the increased activity of
this mutant at these temperatures. The KJ value of lp-AID DI76G at 37°C was between
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that of Hs-AID and lp-AID (0.69 nM), which would explain the elevated activity of this
mutant compared to lp-AID, and the slightly reduced activity of this mutant compared to
Hs-AID at 37°C. We conclude that the Dl76G mutation increases the affinity oflp-AID
for ssDNA, and that this effect is significantly more pronounced at lower temperatures.
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Figure 20. Surface structure models of Hs-AID, Dr-AID, lp-AID and APOBEC3G.
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Figure 20. Surface structure models of Hs-AID, Dr-AID, lp-AID and APOBEC3G.
The surface topology and charge of Hs-AID, Dr-AID, and lp-AID were modeled on the
basis of the solved structure of the APOBEC3G catalytic unit. The top panel shows a
transparent superimposition of the ribbon diagram within the surface. The bottom panel
shows a solid representation of the surface of each model. Positively and negatively
charged residues are coloured red and blue, respectively. The putative catalytic pocket
housing the Zn-coordinating residues are shown in magenta. Arrows mark the position of
Dl76 and the surrounding residues in lp-AID as well as the corresponding residues in Hs-
AID and Dr-AID. Several proximal residues that bind ssDNA in APOBEC3G are
indicated (H367, H374). A putative ssDNA binding groove in Hs-AID is shown by green
dashes.
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Free (nM)
Figure 21. EMSA measuring the binding affinity of AID to ssDNA at
temperatures.
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Figure 21. EMSA measuring the binding affmity of AID to ssDNA at different
temperatures.
EMSA with Hs-AID, lp-AID and lp-AID DI76G binding to the TGCbub7 substrate at
37°C, 2SoC and IS°C. Reactions were carried out with increasing concentrations of
TGCbub7 substrate over a range of 100 fold (from 0.025 nM to 25nM). The fraction of
shifted (bound) and un-shifted substrate was quantified at each substrate concentration
and plotted. Curves with large, medium and small circles represent binding at 37°C, 25°C
and ISoC, respectively. Each data point represents the mean of values obtained from 5-10
independent experiments. The half-saturation values (Kd) and the corresponding 95%
confidence upper limit values for each interaction was determined based on the plotted
curves and shown in Table I. Comparing lp-AID binding at 37°C to 18°C: p=0.008.
Comparing lp-AID DI76G binding at 37°C to ISoC: p=0.005.
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Table 1. Kd values of Hs-AID, lp-AID and lp-AID D176G binding to ssDNA at
various temperatures.
37°C 2SoC 18°C
Kt Upper limit Kt Upper limit Kt Upper limit
(nM)" (nM)b (nM)" (nM)b (nM)" (nM)b
0.15 ± 0.31 ± 0.10±
Hs-AID 0.37 0.52 0.16
0.06 0.09 0.02
1.1 ± 0.14± 0.07±
lp-AID 2.4 0.18 0.12
0.80 0.03 0.02
lp-AID 0.69± 0.05± 0.03 ±
1.6 0.08 0.06
(D176G) 0.38 0.0\ 0.01
"Kt (nM) as detennined by EMSA
bUpper limit value in the 95% confidence range of Kt (nM)
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Table 1. Kd values of Us-AID, lp-AID and lp-AID D176G binding to ssDNA at
various temperatures.
The half-saturation values (Kt) and the corresponding 95% confidence upper limit values
for each interaction was determined based on the plotted curves shown in Figure 21.
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4. Discussion
4.1 Overall rationale and most significant findings
AID is a ssDNA mutating enzyme that initiates secondary antibody diversification
processes, such as SHM and CSR, by catalyzing the deamination of C to U in the
immunonglobulin genes of B lymphocytes. The downstream pathways following this
conversion initiate mutations and double stranded breaks in DNA that result in altered
effector functions of antibodies as well as the diversification and increased affinity of
antibody receptors. However, AID action is not limited and specifically targeted to
immunoglobulin loci. With the potential to produce an effect genome-wide, AID has been
implicated in causing the transformation of activated B cells into leukemia and
lymphoma, disease aggressiveness and drug resistance. The structure of AID is currently
unresolved. As a result, little is known regarding its enzymatic and biochemical
properties. For this reason we investigated the characteristics of human AID in
comparison to the evolutionarily divergent forms from bony fish in order to elucidate
structure-function relationships.
We previously reported that Hs-AID binds to ssD A with high affinity and a long
complex half-life (Larijani et aI., 2005). However, partly because the structure of AID has
not been determined, the molecular basis for this and other enzymatic properties are
unknown. Mutants of human AID with altered WRC specificity or catalytic rates have
been described in the past (Kohli et aI., 2010; Wang et aI., 2009; Wang et aI., 2010).
While these studies have identified critical residues for AID activity, the mechanisms
through which the mutations influence catalysis have not been elucidated. Furthermore,
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the biological relevance of laboratory-generated mutations is unclear. Here we examined
the biochemical properties of purified wild type AID from different species. We chose to
study bony fish AID from zebrafish (Danio rerio) and channel catfish (Jctalurus
punctatus) because their primary AID structure is, to date, the most distant from humans
and therefore likely to possess altered characteristics (Barreto & Magor, 2011; Conticello
et aI., 2005; Wakae et aI., 2006). Previous work in the field had shown that AID from
these bony fish are functional enzymes when transfected into eukaryotic cells or
transformed into bacteria. However, quantifying measurement of the enzymatic activity
of AID was not possible due to limitations of the experimental systems (Barreto et aI.,
2005; Conticello et aI., 2005; Ichikawa et aI., 2006). Said limitations include the selection
imposed by the measurement of AID-mediated antibody resistance gain or GFP reversion
mutations in bacteria and eukaryotic cells, respectively, the presence of downstream DNA
repair pathways altering the levels and patterns of AID-induced mutations, and variation
of AID expression levels. Here we use purified AID in an in vitro free system, without
the potential for selection or 0 A repair, thus allowing for direct comparison of AID
activity amongst species.
We hypothesized that individual sequence differences could manifest in different
biochemical properties, yielding insights into the molecular mechanisms of AID action.
Indeed, we found that wild type bony fish and human AID have different catalytic
efficiencies and that these differences are mediated by a single residue in the C-terminus
of AID.
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4.2 The mechanisms of activity modulation by 0176
In principle, several mechanisms may account for the catalytic differences
mediated by the single residue between lp-AID, lp-AID D176G and Or-AID. It is
unlikely that the DI76G substitution influences deamination catalysis directly since this
residue is not proximal to the putative Zn-coordinating and catalytic residues (in Hs-AID:
H56, E58, C87, C90, lp-AID: H59, E61, C98, CIO) and Dr-AID: H60, E62, C99, C102)
in the primary sequence or the surface model of AID structure (Figure 6, Figure 13 and
Figure 20). On the surface charge model of AID that we generated based on the
determined structure of APOBEC3G (Figure 20), we identified a putative ssDNA binding
groove (Figure 20 bottom left; putative groove denoted by green line, putative catalytic
pocket shown in magenta). This groove is in a similar position to the ssDNA binding
groove of APOBEC3G which has been suggested based on NMR shifts and mutational
studies (Chen et aI., 2008; Holden et aI., 2008). Although it is unclear whether this groove
in AID is involved in binding ssDNA, it is lined with a high number ofpositively charged
amino acids in lp-AID, Or-AID and Hs-AID (Figure 20; shown in blue), which may
provide a basis for our previous finding that Hs-AID binds ssDNA with high affinity
(Larijani & Martin, 2007). However, we noted that in the surface models, the 0176 is
located in the middle of a 3 residue-ridge identifiable in AID from all three species
(0175,0176 and Q179 in lp-AID) that is not located in the putative ssDNA binding
groove (Figure 20, arrows). We thus wondered how this residue influences ssDNA
binding. We found that the 0176 residue is located proximal to several positively charged
residues that are in an equivalent position to residues on APOBEC3G (H367 and H374)
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that have been suggested to bind D A in two studies. One study reported that these
residues change positions upon ssDNA by NMR shift analysis, while another study also
identified the binding groove and found targeted mutation of these residues diminished
APOBEC3G activity, consistent with a role in ssDNA binding (Chen et aI., 2008; Holden
et aI., 2008). Thus, we suggest that by virtue of its proximity to the end of the putative
binding groove, this region of AID plays a role in ssD A binding. In this regard, D176
may exert its influence indirectly through influencing the conformation of a nearby
portion of the putative ssDNA binding groove. This model would be consistent with the
greater negative effect of this residue on ssDNA binding at 37°C, when the overall
protein structure is more flexible. Whatever the mechanism(s) may be, our data indicate
that variations in ssD A binding affinity result in differences in the catalytic activity of
AlD amongst species, and that the carboxyl-terminal region of AlD contains residues that
influence ssDNA binding and thus regulate the enzymatic efficiency of AID.
4.3 The cold adaptation of bony fish AID
The reaction rate and catalytic efficiency of temperate enzymes decreases as
temperature is lowered. Decreased temperatures prevent the enzyme from changing shape
during the catalysis process. However, cold-adapted organisms have evolved by having
modified proteins that function efficiently under such conditions. Increased temperatures
have been shown to affect cold-adapted enzyme by rendering the enzyme more flexible
thus reducing thermal stability (D'Amico et aI., 2002; Feller & Gerday, 2003). This is a
commonality shared among thermosensitive enzymes. Cold adaptation appears in
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poikilothenns, those whose body temperatures match that of the environment in which
they reside, and not in homeothenns such as mammals, whose body temperature is
maintained independently from the external environment (D'Arnico et aI., 2002). Studies
have shown that the fundamental kinetic properties of enzymes are conserved from
species to species when they are within the nonnal physiological range of temperatures
encountered by that species (Feller & Gerday, 2003). We chose to explore this notion in
the context of AID from bony fish in comparison to that from humans.
In an antibiotic resistance screen in E. coli, pufferfish AID was found to be
inactive at 37°C, but was functional at ISoC (Conticello et aI., 2005). While this result
may reflect increased activity of AID at lower temperatures, an alternative explanation is
that bacterial expression at lower temperatures leads to more soluble AID (Coker,
Morgan, & Petersen, 2006; Larijani & Martin, 2007). In a separate report measuring the
activity of lp-AID and Or-AID in a mammalian cell line ( IH-3T3) no increase in
activity was found when the temperature was lowered from 37°C to 28°C, though the
range of temperatures tested were limited presumably by constraints on cell survival
(Wakae et aI., 2006). Here, we demonstrated that different fonns of the AID enzyme
from various species, Hs-AID, Or-AID and lp-AID, showed a preference to deaminate
the TGCbub7 WRC motif sequence but functioned optimally at different temperatures.
In this study and in agreement with previous work, Hs-AID was able to deaminate
preferentially at 37°C (Larijani et aI., 2007). Interestingly, Hs-AID demonstrated
decreasing activity with lessening temperatures (Figure 12). Conversely, we report that
purified lp-AID and Or-AiD exhibit high levels of activity at low temperatures and high
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thermosensitivity, hallmarks of cold adaptation. Thus, bony fish AID are cold adapted at
the enzymatic level.
Two general types of strategies for cold adaptation of enzymes have been
reported; the first is overall increased structural flexibility (Gerday et aI., 1997; Marshall,
1997; Zavodszky et aI., 1998). Low temperatures limit "breathing" and thus cold-adapted
enzymes ought to be more flexible in order to retain the structural mobility required for
catalysis at lower temperatures. The second is increased flexibility or accessibility of
substrate binding grooves, possibly by modifying the electrostatic environment in the
proximity of grooves (D'Amico et aI., 2002; Feller & Gerday, 2003). Our data suggest
that temperature-sensitive ssDNA binding affinity of AID determines catalytic efficacy,
and together with structural models of the position of D 176, are supportive of the latter
mechanism. Based on our data comparing the thermosensitivity of hybrid AIDs (Figure
19), we suggest that residues located in the -terminus are likely important for this
attribute of fish AID.
4.4 The significance of our findings with respect to the evolution of AID
Adaptive immunity and the genetic mechanisms responsible for antibody
diversification, such as V(D)J recombination and SHM, are cellular anatomical features
that first arose in the Gnathostomata, the superclass representing all jawed vertebrates.
The earliest Gnathostomata species are cartilagenous fish (e.g. sharks) (Flajnik &
Kasahara, 2010; Pancer & Cooper, 2006). Sharks possess antibody affinity maturation,
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though to date only a fragment of shark AID has been cloned (Conticello et aI., 2005;
Dooley et aI., 2006). Within the Gnathostomata superclass, Osteichthyes, characterizing
bony fish, appears to be the earliest species identified to date to undergo SHM, contain
full known sequences of AJD, and are the earliest vertebrates for which AID function
relative to the protein structure has been examined. Bony fish are the earliest divergent
jawed vertebrates from which AID has been cloned and compared to humans. From the
representative species of each evolutionary class examined, including Osteichthyes,
Amphibia, Aves, and Mammalian, zebrafish and catfish are the earliest diverged bony fish
species with sequenced AID and they differ at residue 176. In more recently derived bony
fish there have been a mixture of outcomes with sticklebacks and the two pufferfishes
(Takifugu & Tetraodon) all having E176, and Medaka and Ayu sharing the GI76 with
zebrafish (unpublished observations). Consistent with our findings, replacement of this
residue in Tr-AID also improved the enzyme's activity in a bacterial papillation assay
(Wang et aI., 2009).
It is possible that the differences in the enzymatic efficiency of human and bony
fish AID are mere byproducts of sequence divergence. Alternatively, such differences
may be of significance with respect to the evolutionary path of AID. We propose the
latter for several reasons: first, although zebrafish and channel catfish belong to the sister
taxa of Cypriniformes and Siluriformes respectively, there is evidence to suggest that
Siluriformes arose earlier (Nakatani et aI., 2011; Steinke, Salzburger, & Meyer, 2006).
Second, Dr-AJD is more closely related to Hs-AID than lp-AID is to Hs-AID (Figure 6,
Figure 7). Third, the G residue of Or-AID is conserved in all land-dwelling species.
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Fourth, APOBEC2 which is an ancestral member of the APOBEC family (expressed in
cartilaginous fish) contains a D residue similar to Ip-AlD, while APOBEC3 enzymes
which are the most recently diverged members (primate specific) contain a G residue, in
the equivalent position. Taken together, these observations suggest that D176 was the
ancestral residue in AID and that its alteration into a G residue during the evolution of
AlD resulted in a more active enzyme. It is tempting to speculate that this event reflects
an increase in evolutionary pressure on adaptive immunity due to environmental
pathogens.
The AlD/APOBEC family is believed to have evolved from the tRNA adenosine
deaminases, present from bacteria to metazoans (Conticello, 2008). Partial AID
sequences have been identified in the shark, a member of the cartilaginous fishes that
arose prior to bony fish. Sharks and rays immunologbulin genes possess a single v-
element that may recombine with a single J- or DJ-element, believed by many to be a
very early immunologbulin gene (Greenberg et aI., 1995). Some have argued that sharks
can develop a considerable primary antibody repertoire without the need for further
diversification through AID by clustering multiple Ig loci and combining up to three 0-
elements into a single VDDDJ exon (Greenberg et aI., 1995; Zhao et aI., 2005).
Conversely, others have stated that sharks use AlD for secondary repertoire development,
supported by observations of accumulated mutations on Ig light chain genes expressed in
secondary lymphoid organs representative of antigen driven selection (Dooley et aI.,
2006). Limited studies of elasmobranches and their use of somatic mutation have been
performed and future studies examining the homology of cartilaginous AlD to that of
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bony fish as well as similarities and differences in enzymatic properties will shed light on
the functionality of the earliest forms of AID.
4.5 Conclusions and future work
In this study, we examined the biochemical properties of purified wild type AID
from different species including bony fish channel catfish, zebrafish and human. We
hypothesized that AID from divergent species were likely to possess altered properties
which could be explained by sequence differences, thus, yielding insight into the
molecular mechanism of AID action. We found that wild type bony fish and human AID
have distinct catalytic efficiencies. Cross-species differences in AJD expression and post-
translational modifications may counterbalance the inherent catalytic differences between
lp-AID and Dr-AID, in vivo. For instance, phosphorylation of Hs-AID at S38 has been
shown to modulate its activity by promoting interaction with replication protein A (RPA)
(Chaudhuri, Chan, & Frederick, 2004). In this regard, one notable difference is that like
Hs-AID, Jp-AID has a S38 residue. In contrast, Dr-AID lacks this residue, but has a
phosphomimetic D44 residue that has been shown to interact with RPA (Basu, Wang, &
Frederick, 2008). Given these differences, it will be of interest to compare the in vivo
levels of AID-induced mutations and double-strand breaks between the two fish.
Ongoing and future studies will investigate the biochemical properties of AID
from various species including cartilaginous fish, multiple other bony fish and tetrapods.
Structural models will be generated to guide and assist data interpretation, in a similar
94
manner as described in this thesis. Once AID from various species have been
characterised in vitro, it will be of interest to detennine whether the differences in activity
reflect differences in DNA-damage levels induced by AID in vivo.
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